Imbruvica (Ibrutinib) is an FDA approved targeted therapy treatment for some forms of blood and lymph node cancers, including mantle cell lymphoma and lymphocytic leukemia. Dr. Stephen Lemon, a medical oncologist, talks about how this treatment works, including what types of side effects it may cause patients during treatment.
Click on the buttons below to view more videos that we have produced
Facebook
Twitter
LinkedIn
Email